Cryoport Inc

CYRX remains in a healthy uptrend with price above rising 9/20/50 EMAs and forming higher highs and higher lows. The recent pullback into the 20-day and 50-day EMAs in the $15.84–$15.09 area has held, demonstrating demand absorption at key support. Momentum indicators remain neutral, providing room for further upside without overbought constraints. Given the continuation structure and steady EMAs, we recommend initiating a long position now on this pullback into support, while monitoring resistance at prior highs. Primary risks include a breakdown below the EMAs and failure to clear the $16.42 resistance level.

• ↑Revenue up 15% YoY to $49M driven by life sciences services
• ↑Achieved first positive adjusted EBITDA of $0.4M, boosting profit runway
• ↓Guidance held at $192–196M due to geopolitical and macro uncertainties